Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 04, 2017 Filed Feb 7, 2017 17:15 UTC |
Brooks Conrad D.EVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 2,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008408 · doc4.xml · derivative · entry 4 Brooks Conrad D. · CIK 0001694171 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,126 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon vesting, each restricted stock unit will be equal in value to one common share (50% of the restricted stock units will be settled in common shares and 50% will be settled in cash). F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning February 4, 2014. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning February 4, 2014. Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 17:15 UTC |
Brooks Conrad D.EVP, General Counsel & Sec
|
Tax withholdingCommon Shares | 411 | $66.66 | $27,397.26 |
DisclosureSEC source: 0001209191-17-008408 · doc4.xml · nonDerivative · entry 3 Brooks Conrad D. · CIK 0001694171 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,935 Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 17:15 UTC |
Brooks Conrad D.EVP, General Counsel & Sec
|
Disposition to issuerCommon Shares | 1,063 | $66.66 | $70,859.58 |
DisclosureSEC source: 0001209191-17-008408 · doc4.xml · nonDerivative · entry 2 Brooks Conrad D. · CIK 0001694171 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,346 Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 17:15 UTC |
Brooks Conrad D.EVP, General Counsel & Sec
|
Exercise / conversionCommon Shares | 2,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008408 · doc4.xml · nonDerivative · entry 1 Brooks Conrad D. · CIK 0001694171 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:19 UTC |
O'SHAUGHNESSY JAMESEVP, CAO & Corp Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 1,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008412 · doc4.xml · derivative · entry 3 O'SHAUGHNESSY JAMES · CIK 0001394386 · EVP, CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,876 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon vesting, each restricted stock unit will be equal in value to one common share (50% of the restricted stock units will be settled in common shares and 50% will be settled in cash). F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning February 4, 2014. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning February 4, 2014. Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:19 UTC |
O'SHAUGHNESSY JAMESEVP, CAO & Corp Controller
|
Disposition to issuerCommon Shares | 938 | $66.66 | $62,527.08 |
DisclosureSEC source: 0001209191-17-008412 · doc4.xml · nonDerivative · entry 2 O'SHAUGHNESSY JAMES · CIK 0001394386 · EVP, CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,551 Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:19 UTC |
O'SHAUGHNESSY JAMESEVP, CAO & Corp Controller
|
Exercise / conversionCommon Shares | 1,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008412 · doc4.xml · nonDerivative · entry 1 O'SHAUGHNESSY JAMES · CIK 0001394386 · EVP, CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:18 UTC |
NICHOLS JOHN DRAKECEO, AXIS Re
|
Tax withholdingCommon Shares | 3,433 | $66.66 | $228,843.78 |
DisclosureSEC source: 0001209191-17-008411 · doc4.xml · nonDerivative · entry 1 NICHOLS JOHN DRAKE · CIK 0001256130 · CEO, AXIS Re 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,691 Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:17 UTC |
Henry JosephEVP and CFO
|
Tax withholdingCommon Shares | 2,577 | $66.66 | $171,782.82 |
DisclosureSEC source: 0001209191-17-008410 · doc4.xml · nonDerivative · entry 1 Henry Joseph · CIK 0001552158 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,039 Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:16 UTC |
DiSipio Christopher N.CEO, Accident & Health
|
Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008409 · doc4.xml · derivative · entry 4 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon vesting, each restricted stock unit will be equal in value to one common share (50% of the restricted stock units will be settled in common shares and 50% will be settled in cash). F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning February 4, 2014. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning February 4, 2014. Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:16 UTC |
DiSipio Christopher N.CEO, Accident & Health
|
Tax withholdingCommon Shares | 1,132 | $66.66 | $75,459.12 |
DisclosureSEC source: 0001209191-17-008409 · doc4.xml · nonDerivative · entry 3 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,142 Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:16 UTC |
DiSipio Christopher N.CEO, Accident & Health
|
Disposition to issuerCommon Shares | 3,125 | $66.66 | $208,312.50 |
DisclosureSEC source: 0001209191-17-008409 · doc4.xml · nonDerivative · entry 2 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,274 Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 22:16 UTC |
DiSipio Christopher N.CEO, Accident & Health
|
Exercise / conversionCommon Shares | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008409 · doc4.xml · nonDerivative · entry 1 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 16:28 UTC |
Brooks Conrad D.EVP, General Counsel & Sec
|
GrantRestricted Stock Units · Derivative | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007107 · doc4.xml · derivative · entry 2 Brooks Conrad D. · CIK 0001694171 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546 Underlying: Common Shares · 546 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit will be equal in value to one common share (50% of the restricted stock units will be settled in common shares and 50% will be settled in cash). F3 · derivative.exercise_date: Represents a guaranteed minimum award of performance-based restricted stock units. The award may increase up to 10,934 restricted stock units provided that certain Company performance conditions are satisfied. The award will be eligible to vest in a single installment on March 1, 2020. F3 · derivative.expiration_date: Represents a guaranteed minimum award of performance-based restricted stock units. The award may increase up to 10,934 restricted stock units provided that certain Company performance conditions are satisfied. The award will be eligible to vest in a single installment on March 1, 2020. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 16:28 UTC |
Brooks Conrad D.EVP, General Counsel & Sec
|
GrantRestricted Stock Units · Derivative | 5,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007107 · doc4.xml · derivative · entry 1 Brooks Conrad D. · CIK 0001694171 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,467 Underlying: Common Shares · 5,467 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit will be equal in value to one common share (50% of the restricted stock units will be settled in common shares and 50% will be settled in cash). F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 1, 2018. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 1, 2018. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:36 UTC |
Wilson Peter WCEO, AXIS Insurance
|
GrantCommon Shares | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007119 · doc4.xml · nonDerivative · entry 2 Wilson Peter W · CIK 0001453918 · CEO, AXIS Insurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,341 F1 · shares: Represents a guaranteed minimum award of performance-based restricted stock units. The award may increase up to 14,060 restricted stock units provided that certain Company performance conditions are satisfied. The award will be eligible to vest in a single installment on March 1, 2020. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:36 UTC |
Wilson Peter WCEO, AXIS Insurance
|
GrantCommon Shares | 8,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007119 · doc4.xml · nonDerivative · entry 1 Wilson Peter W · CIK 0001453918 · CEO, AXIS Insurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,638 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:32 UTC |
Henry JosephEVP and CFO
|
GrantCommon Shares | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007115 · doc4.xml · nonDerivative · entry 2 Henry Joseph · CIK 0001552158 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,616 F1 · shares: Represents a guaranteed minimum award of performance-based restricted stock units. The award may increase up to 18,746 restricted stock units provided that certain Company performance conditions are satisfied. The award will be eligible to vest in a single installment on March 1, 2020. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:32 UTC |
Henry JosephEVP and CFO
|
GrantCommon Shares | 10,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007115 · doc4.xml · nonDerivative · entry 1 Henry Joseph · CIK 0001552158 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,679 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:27 UTC |
BENCHIMOL ALBERTDirector · President and CEO
|
GrantCommon Shares | 3,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007103 · doc4.xml · nonDerivative · entry 2 BENCHIMOL ALBERT · CIK 0001185870 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,184 F1 · shares: Represents a guaranteed minimum award of performance-based restricted stock units. The award may increase up to 78,112 restricted stock units provided that certain Company performance conditions are satisfied. The award will be eligible to vest in a single installment on March 1, 2020. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:27 UTC |
BENCHIMOL ALBERTDirector · President and CEO
|
GrantCommon Shares | 44,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007103 · doc4.xml · nonDerivative · entry 1 BENCHIMOL ALBERT · CIK 0001185870 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,279 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:35 UTC |
O'SHAUGHNESSY JAMESEVP, CAO & Corp Controller
|
GrantRestricted Stock Units · Derivative | 4,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007118 · doc4.xml · derivative · entry 1 O'SHAUGHNESSY JAMES · CIK 0001394386 · EVP, CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,452 Underlying: Common Shares · 4,452 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit will be equal in value to one common share (50% of the restricted stock units will be settled in common shares and 50% will be settled in cash). F2 · derivative.exercise_date: The restricted stock units will vest in four equal annual installments beginning March 1, 2018. F2 · derivative.expiration_date: The restricted stock units will vest in four equal annual installments beginning March 1, 2018. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:33 UTC |
NICHOLS JOHN DRAKECEO, AXIS Re
|
GrantCommon Shares | 1,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007117 · doc4.xml · nonDerivative · entry 2 NICHOLS JOHN DRAKE · CIK 0001256130 · CEO, AXIS Re 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,124 F1 · shares: Represents a guaranteed minimum award of performance-based restricted stock units. The award may increase up to 21,870 restricted stock units provided that certain Company performance conditions are satisfied. The award will be eligible to vest in a single installment on March 1, 2020. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:33 UTC |
NICHOLS JOHN DRAKECEO, AXIS Re
|
GrantCommon Shares | 12,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007117 · doc4.xml · nonDerivative · entry 1 NICHOLS JOHN DRAKE · CIK 0001256130 · CEO, AXIS Re 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,031 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:31 UTC |
DiSipio Christopher N.CEO, Accident & Health
|
GrantCommon Shares | 562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007112 · doc4.xml · nonDerivative · entry 2 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,149 F1 · shares: Represents a guaranteed minimum award of performance-based restricted stock units. The award may increase up to 11,248 restricted stock units provided that certain Company performance conditions are satisfied. The award will be eligible to vest in a single installment on March 1, 2020. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:31 UTC |
DiSipio Christopher N.CEO, Accident & Health
|
GrantCommon Shares | 6,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007112 · doc4.xml · nonDerivative · entry 1 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,587 Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 16:28 UTC |
Friedman Robert L.Director
|
GrantCommon Shares | 3,251 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-004475 · doc4.xml · nonDerivative · entry 1 Friedman Robert L. · CIK 0001085357 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,797 F1 · price: Common Shares issued as director's fees using January 17, 2017 closing price of $64.59. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 16:27 UTC |
Boisseau JaneDirector
|
GrantCommon Shares | 1,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-004473 · doc4.xml · nonDerivative · entry 1 Boisseau Jane · CIK 0001563575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,364 F1 · price: Common Shares issued as director's fees using January 17, 2017 closing price of $64.59. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 16:33 UTC |
Zeller WilhelmDirector
|
GrantCommon Shares | 3,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-004494 · doc4.xml · nonDerivative · entry 1 Zeller Wilhelm · CIK 0001467886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,733 F1 · price: Common Shares issued as director's fees using January 17, 2017 closing price of $64.59. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 16:30 UTC |
Lister Cheryl-AnnDirector
|
GrantCommon Shares | 387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-004478 · doc4.xml · nonDerivative · entry 1 Lister Cheryl-Ann · CIK 0001445894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,647 F1 · price: Common Shares issued as director's fees using January 17, 2017 closing price of $64.59. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 21:31 UTC |
SMITH HENRY BDirector
|
GrantCommon Shares | 2,032 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-004483 · doc4.xml · nonDerivative · entry 1 SMITH HENRY B · CIK 0001285737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,559 F1 · price: Common Shares issued as director's fees using January 17, 2017 closing price of $64.59. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 16:29 UTC |
KEANE MAURICE ADirector
|
GrantCommon Shares | 1,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-004477 · doc4.xml · nonDerivative · entry 1 KEANE MAURICE A · CIK 0001249937 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,273 F1 · price: Common Shares issued as director's fees using January 17, 2017 closing price of $64.59. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 21:31 UTC |
Young AliceDirector
|
GrantCommon Shares | 1,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-004489 · doc4.xml · nonDerivative · entry 1 Young Alice · CIK 0001570706 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,570 F1 · price: Common Shares issued as director's fees using January 17, 2017 closing price of $64.59. Read SEC document |
| January 04, 2017 Filed Jan 5, 2017 16:29 UTC |
BUTT MICHAEL ADirector
|
SaleCommon Shares | 34,026 | $65.85 | $2,240,697.17 |
DisclosureSEC source: 0001209191-17-002095 · doc4.xml · nonDerivative · entry 2 BUTT MICHAEL A · CIK 0001249919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965,956 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The 34,026 shares sold consist of the trades listed in Exhibit 1. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 16:29 UTC |
BUTT MICHAEL ADirector
|
SaleCommon Shares | 124,920 | $65.25 | $8,151,454.73 |
DisclosureSEC source: 0001209191-17-002095 · doc4.xml · nonDerivative · entry 1 BUTT MICHAEL A · CIK 0001249919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999,982 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The 124,920 shares sold consist of the trades listed in Exhibit 1. Read SEC document |
| December 28, 2016 Filed Jan 3, 2017 23:26 UTC |
Gieryn Richard T JREVP, General Counsel & Sec
|
GiftCommon Shares | 7,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000439 · doc4.xml · nonDerivative · entry 1 Gieryn Richard T JR · CIK 0001373524 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,358 Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 22:00 UTC |
BENCHIMOL ALBERTDirector · President and CEO
|
GiftCommon Shares | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155194 · doc4.xml · nonDerivative · entry 1 BENCHIMOL ALBERT · CIK 0001185870 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,365 Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 21:24 UTC |
NICHOLS JOHN DRAKECEO, AXIS Re
|
GrantCommon Shares | 22,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-154410 · doc4.xml · nonDerivative · entry 1 NICHOLS JOHN DRAKE · CIK 0001256130 · CEO, AXIS Re 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,455 F1 · shares: On December 7, 2016, the Company's Compensation Committee determined satisfaction of performance criteria for performance-based restricted stock units granted on February 4, 2014. This amount represents additional performance-based restricted stock units that have been earned pursuant to the award in addition to the guaranteed minimum payout of 1,579 restricted stock units which were previously reported on February 6, 2014. The restricted stock units will vest in a single installment on March 1, 2017. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 21:23 UTC |
Henry JosephEVP and CFO
|
GrantCommon Shares | 18,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-154409 · doc4.xml · nonDerivative · entry 1 Henry Joseph · CIK 0001552158 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,900 F1 · shares: On December 7, 2016, the Company's Compensation Committee determined satisfaction of performance criteria for performance-based restricted stock units granted on February 4, 2014. This amount represents additional performance-based restricted stock units that have been earned pursuant to the award in addition to the guaranteed minimum payout of 1,353 restricted stock units which were previously reported on February 6, 2014. The restricted stock units will vest in a single installment on March 1, 2017. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 21:21 UTC |
DiSipio Christopher N.CEO, Accident & Health
|
GrantRestricted Stock Units · Derivative | 11,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-154406 · doc4.xml · derivative · entry 1 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,180 Underlying: Common Stock · 11,368 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit will be equal in value to one common share (50% of the restricted stock units will be settled in common shares and 50% will be settled in cash). F2 · shares: On December 7, 2016, the Company's Compensation Committee determined satisfaction of performance criteria for performance-based restricted stock units granted on February 4, 2014. This amount represents additional performance-based restricted stock units that have been earned pursuant to the award in addition to the guaranteed minimum payout of 812 restricted stock units which were previously reported on February 6, 2014. The restricted stock units will vest in a single installment on March 1, 2017. F2 · derivative.exercise_date: On December 7, 2016, the Company's Compensation Committee determined satisfaction of performance criteria for performance-based restricted stock units granted on February 4, 2014. This amount represents additional performance-based restricted stock units that have been earned pursuant to the award in addition to the guaranteed minimum payout of 812 restricted stock units which were previously reported on February 6, 2014. The restricted stock units will vest in a single installment on March 1, 2017. F2 · derivative.expiration_date: On December 7, 2016, the Company's Compensation Committee determined satisfaction of performance criteria for performance-based restricted stock units granted on February 4, 2014. This amount represents additional performance-based restricted stock units that have been earned pursuant to the award in addition to the guaranteed minimum payout of 812 restricted stock units which were previously reported on February 6, 2014. The restricted stock units will vest in a single installment on March 1, 2017. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 21:22 UTC |
Gieryn Richard T JREVP, General Counsel & Sec
|
GrantRestricted Stock Units · Derivative | 11,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-154408 · doc4.xml · derivative · entry 1 Gieryn Richard T JR · CIK 0001373524 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,180 Underlying: Common Stock · 11,368 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit will be equal in value to one common share (50% of the restricted stock units will be settled in common shares and 50% will be settled in cash). F2 · shares: On December 7, 2016, the Company's Compensation Committee approved the payout for performance-based restricted stock units pursuant to an award granted on February 4, 2014. This represents the performance-based restricted stock units that have been earned pursuant to the award less the guaranteed minimum payout of 812 restricted stock units which were previously reported on February 6, 2014. Under the award agreement, the restricted stock units are scheduled to vest in a single installment on March 1, 2017. F2 · derivative.exercise_date: On December 7, 2016, the Company's Compensation Committee approved the payout for performance-based restricted stock units pursuant to an award granted on February 4, 2014. This represents the performance-based restricted stock units that have been earned pursuant to the award less the guaranteed minimum payout of 812 restricted stock units which were previously reported on February 6, 2014. Under the award agreement, the restricted stock units are scheduled to vest in a single installment on March 1, 2017. F2 · derivative.expiration_date: On December 7, 2016, the Company's Compensation Committee approved the payout for performance-based restricted stock units pursuant to an award granted on February 4, 2014. This represents the performance-based restricted stock units that have been earned pursuant to the award less the guaranteed minimum payout of 812 restricted stock units which were previously reported on February 6, 2014. Under the award agreement, the restricted stock units are scheduled to vest in a single installment on March 1, 2017. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 22:00 UTC |
DiSipio Christopher N.CEO, Accident & Health
|
SaleCommon Shares | 500 | $61.04 | $30,520.00 |
DisclosureSEC source: 0001209191-16-151257 · doc4.xml · nonDerivative · entry 1 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,120 Read SEC document |
| November 16, 2016 Filed Jan 3, 2017 23:27 UTC Amendment |
DiSipio Christopher N.CEO, Accident & Health
|
GiftCommon Shares | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000441 · doc4a.xml · nonDerivative · entry 1 DiSipio Christopher N. · CIK 0001559051 · CEO, Accident & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,120 F1 · kind: This Amendment is being filed to correctly report the transaction as a donation of stock rather than a sale. F1 · price: This Amendment is being filed to correctly report the transaction as a donation of stock rather than a sale. Read SEC document |
| October 14, 2016 Filed Oct 17, 2016 17:11 UTC |
BUTT MICHAEL ADirector
|
SaleCommon Shares | 36,773 | $57.01 | $2,096,505.95 |
DisclosureSEC source: 0001209191-16-146074 · doc4.xml · nonDerivative · entry 2 BUTT MICHAEL A · CIK 0001249919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,902 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The 36,773 shares sold consist of the trades listed in Exhibit 1. Read SEC document |
| October 13, 2016 Filed Oct 17, 2016 17:11 UTC |
BUTT MICHAEL ADirector
|
SaleCommon Shares | 3,900 | $57.00 | $222,312.87 |
DisclosureSEC source: 0001209191-16-146074 · doc4.xml · nonDerivative · entry 1 BUTT MICHAEL A · CIK 0001249919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,161,675 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The 3,900 shares sold consist of the trades listed in Exhibit 1. Read SEC document |
| September 09, 2016 Filed Sep 12, 2016 22:01 UTC |
Gieryn Richard T JREVP, General Counsel & Sec
|
SaleCommon Shares | 10,400 | $56.15 | $583,974.56 |
DisclosureSEC source: 0001209191-16-140978 · doc4.xml · nonDerivative · entry 1 Gieryn Richard T JR · CIK 0001373524 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,958 F1 · price: The 10,400 shares sold consist of the trades listed in Exhibit 1. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 17:17 UTC |
BUTT MICHAEL ADirector · Chairman of the Board
|
SaleCommon Shares | 31,345 | $57.02 | $1,787,222.94 |
DisclosureSEC source: 0001209191-16-140595 · doc4.xml · nonDerivative · entry 2 BUTT MICHAEL A · CIK 0001249919 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,165,575 F2 · price: The 31,345 shares sold consist of the trades listed in Exhibit 1. Read SEC document |
| September 02, 2016 Filed Sep 8, 2016 17:17 UTC |
BUTT MICHAEL ADirector · Chairman of the Board
|
SaleCommon Shares | 19,036 | $57.01 | $1,085,190.96 |
DisclosureSEC source: 0001209191-16-140595 · doc4.xml · nonDerivative · entry 1 BUTT MICHAEL A · CIK 0001249919 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,196,920 F1 · price: The 19,036 shares sold consist of the trades listed in Exhibit 1. Read SEC document |
| July 01, 2003 Filed Jul 3, 2003 18:20 UTC |
JPMORGAN CHASE & COFormer 10% Owner
|
SaleCommon Stock | 1,190,840 | $20.68 | $24,626,571.20 |
DisclosureSEC source: 0000019617-03-000373 · jpm11.xml · nonDerivative · entry 1 J P MORGAN CHASE & CO · CIK 0000019617 · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 14,815,536 F1 · ownership.nature: The Reporting Person beneficially owns equity securities of the Issuer indirectly through wholly owned entities, either directly or indirectly. The Reporting Person disclaims beneficial ownership in the securities to the extent it exceeds its pecuniary interest therein. These entities sold common shares of the Issuer. The following sets forth the applicable selling entity and the aggregate amount of common shares sold by such entity: J.P. Morgan Partners (BHCA), L.P. - 633,360 shares; J.P. Morgan Partners Global Investors, L.P. - 3,039 shares; J.P. Morgan Partners Global Investors A, L.P. - 10,129 shares; J.P. Morgan Partners Global Investors (Cayman), L.P. - 50,919 shares; J.P. Morgan Partners Global Investors (Cayman) II, L.P. - 5,674 shares; J.P. Morgan Partners Global Investors (Cayman) III, L.P. - 57,889 shares; J.P. Morgan Partners Global Investors (Cayman) IV, L.P. - 42,962 shares; J.P. Morgan Partners Capital, L.P. - 88,979 shares; and J.P. Morgan Partners Corsair II Offshore Capital Partners, L.P. - 297,889 shares. Read SEC document |
| Date not disclosed Filed Jun 30, 2003 19:58 UTC |
JPMORGAN CHASE & CO10% owner
|
OtherCommon Stock | 4,004,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000019617-03-000356 · jpm6.xml · nonDerivative · entry 9 J P MORGAN CHASE & CO · CIK 0000019617 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: Not disclosed F9 · ownership.nature: The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Corsair II Offshore Capital Partners, L.P. ("Corsair"), a portion of which may be deemed attributable to the Reporting Person because its General Partner, Corsair II Offshore, LLC is an indirect, wholly owned subsidiary of the Reporting Person. The actual pro rata portion of such beneficial ownership that may be deemed attributable to the Reporting Person is not readily determinable because it is subject to several variables, including the internal rate of return and vesting within BHCA and within its general partner. The Reporting Person disclaims beneficial ownership in the securities to the extent it exceeds its pecuniary interest therein Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.